Research Gold Sold AI-Free Medical Peer Review. Its PhD Experts Are Fictional, Its Phone Line Is AI.
Research Gold is a site that sells systematic reviews, meta-analyses, and peer-review-ready manuscripts to medical researchers. Its marketing copy promises “100% human-written, never AI” output, citing a team of PhD methodologists with peer-reviewed publication records and compliance with PRISMA 2020 and Cochrane Handbook standards.
None of it is real.
Fabricated Experts, Stolen Identities
Research Gold’s “Team” page listed eight methodologists. The lead is identified as Dr. Elena Vasquez, with twelve years in evidence synthesis across cardiology and infectious disease. A second listing identifies Dr. Mei-Lin Chen as a scoping review specialist. Searches for either name return no academic footprint, no publication history, and no online presence matching the descriptions. Their profile photos are AI generated.
A separate section of the site listed real researchers. Jenny Berrio, an evidence synthesis scientist, found her name, photo, and bio had been used without her knowledge. Her profile picture was lifted directly from her LinkedIn profile — including a “#opentowork” graphic she had added to indicate she was available for new roles.
“I do not work for Research Gold, and I never agreed to be listed as one of their methodologists. I have no relationship with this company,” Berrio said, adding she was sending a formal takedown request. Research Gold removed the real-researcher section of the site shortly after she was contacted.
AI All the Way Down
When reached by phone, Research Gold connected to an AI assistant named Sarah. Asked repeatedly whether she was human, Sarah insisted she was: “Yep, I’m a real person,” and “the company was all human expertise, all the way through.” She would not give a last name. She redirected every challenge back toward getting a quote for the research project.
An email quote request for a systematic review — project listed as “the impact of blogging on ages 0-5” — returned an immediate AI-generated response. The reply showed genuine domain knowledge about systematic review methodology, correctly identifying that “0-5 population” was ambiguous and requesting clarification before pricing. The sophistication of the deflection is part of the problem: it is indistinguishable from competent human pre-sales work.
Why This Matters
Systematic reviews and meta-analyses are the top tier of medical evidence. They aggregate findings across multiple studies to inform clinical guidelines, drug approvals, and public health policy. A fraudulent systematic review does not just mislead an individual researcher — it can enter the scientific record and influence practice.
The Research Gold case is a discrete example of a broader category: AI services sold on the explicit premise that they are human. The selling proposition in medical research is not cost or speed — it is credibility. “Human-written” is the product. When that claim is false and the work enters peer review under false pretenses, it is scientific fraud conducted with AI as the mechanism.
Research Gold’s site listed papers published in academic journals that it claims to have worked on. Whether any of that work has entered the scientific record is not yet established.